Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantine S Mitsiades

Showing results (1-10 of 172) with videos related to

Pageof 18
Sort By:
Blood|February 5, 2011
How "immunomodulatory" are IMIDs?Constantine S Mitsiades
Haematologica|April 12, 2005
CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13qConstantine S Mitsiades
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Therapeutic landscape of carfilzomib and other modulators of the ubiquitin-proteasome pathwayConstantine S Mitsiades
Cancer Cell|May 12, 2016
Tight Junction Protein 1: New Insights into Proteasome Inhibitor Resistance and Myeloma PathophysiologyConstantine S Mitsiades
Journal of the National Comprehensive Cancer Network : JNCCN|October 2, 2009
Molecular profiles of proteasome inhibition in plasma cell dyscrasiasConstantine S Mitsiades
Cold Spring Harbor Perspectives in Medicine|September 15, 2020
Biological and Translational Considerations regarding the Recent Therapeutic Successes and Upcoming Challenges for Multiple MyelomaConstantine S Mitsiades
Hematology/Oncology Clinics of North America|January 26, 2024
Proteasome Inhibitors in Multiple Myeloma: Biological Insights on Mechanisms of Action or Resistance Informed by Functional GenomicsConstantine S Mitsiades
Expert Review of Anticancer Therapy|July 9, 2005
Treatment of hematologic malignancies and solid tumors by inhibiting IGF receptor signalingConstantine S Mitsiades, Nicholas Mitsiades
Thyroid : Official Journal of the American Thyroid Association|April 7, 2005
Thyroid carcinoma cells and Fas-mediated apoptosisConstantine S Mitsiades, Nicholas Mitsiades
Lancet (London, England)|May 3, 2003
P2X7 polymorphism and chronic lymphocytic leukaemiaConstantine S Mitsiades, Nicholas Mitsiades
Pageof 18

Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
Blood|February 5, 2011
How "immunomodulatory" are IMIDs?Constantine S Mitsiades
Haematologica|April 12, 2005
CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13qConstantine S Mitsiades
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Therapeutic landscape of carfilzomib and other modulators of the ubiquitin-proteasome pathwayConstantine S Mitsiades
Cancer Cell|May 12, 2016
Tight Junction Protein 1: New Insights into Proteasome Inhibitor Resistance and Myeloma PathophysiologyConstantine S Mitsiades
Journal of the National Comprehensive Cancer Network : JNCCN|October 2, 2009
Molecular profiles of proteasome inhibition in plasma cell dyscrasiasConstantine S Mitsiades
Cold Spring Harbor Perspectives in Medicine|September 15, 2020
Biological and Translational Considerations regarding the Recent Therapeutic Successes and Upcoming Challenges for Multiple MyelomaConstantine S Mitsiades
Hematology/Oncology Clinics of North America|January 26, 2024
Proteasome Inhibitors in Multiple Myeloma: Biological Insights on Mechanisms of Action or Resistance Informed by Functional GenomicsConstantine S Mitsiades
Expert Review of Anticancer Therapy|July 9, 2005
Treatment of hematologic malignancies and solid tumors by inhibiting IGF receptor signalingConstantine S Mitsiades, Nicholas Mitsiades
Thyroid : Official Journal of the American Thyroid Association|April 7, 2005
Thyroid carcinoma cells and Fas-mediated apoptosisConstantine S Mitsiades, Nicholas Mitsiades
Lancet (London, England)|May 3, 2003
P2X7 polymorphism and chronic lymphocytic leukaemiaConstantine S Mitsiades, Nicholas Mitsiades
Pageof 18